Reuters Indiaflipped into WorldArthritis Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials Reuters India - Matthias BlamontFILE PHOTO: The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau PARIS (Reuters) - Sanofi has temporarily stopped recruiting new COVID-19 for
BuzzFeed Newsflipped into Latest NewsScience More Than 180 Scientists Are Demanding That The Team Behind A Massive Hydroxychloroquine Study Share Their Data buzzfeednews.com - Stephanie M. Lee The study, which found that patients treated with hydroxychloroquine were more likely to die, just got a correction, though its conclusions remain …
MEA WorldWideflipped into NewsCancer Coronavirus patients with cancer are more likely to die as compared to others, studies show meaww.com - MEAWW The new coronavirus can be dangerous for cancer patients. People with cancer who develop Covid-19 are much more likely to die from the disease within …
AvatarLeeflipped into Flu/EpidemicsArthritis Hydroxychloroquine prescriptions surged 2,000% in March when Trump touted malaria drug CNBC - Berkeley Lovelace Jr. U.S. prescriptions for malaria drug hydroxychloroquine surged nearly 2,000% in March when President Donald Trump first promoted the drug as a …
The Washington Postflipped into BusinessBusiness Trump-fueled promotion of unproved coronavirus drug generated spike in prescriptions, study finds The Washington Post - Dan Keating and Adrian BlancoPublicity about a small study of a potential covid-19 treatment was enough to create a 200 percent increase in hydroxychloroquine and chloroquine prescriptions in March. Although the biggest surge was
Popular ScienceArthritis Hydroxychloroquine isn’t the miracle COVID-19 treatment many hoped it would be Popular Science - Claire MaldarelliHydroxychloroquine has had a bit of a notorious reputation since the drug was first proposed as a treatment for COVID-19. Without much experience to go on, researchers and doctors jumped into trials in
